| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.175 | 8.845 | 8.103 | 6.719 | 7.545 | 6.282 | 14.785 | 21.891 | 22.743 | 21.242 |
| Total Income - EUR | 11.175 | 8.845 | 8.103 | 6.719 | 7.545 | 6.282 | 16.742 | 23.740 | 22.934 | 22.573 |
| Total Expenses - EUR | 3.781 | 4.200 | 4.171 | 4.107 | 3.182 | 2.521 | 3.644 | 6.630 | 13.169 | 13.325 |
| Gross Profit/Loss - EUR | 7.395 | 4.644 | 3.932 | 2.611 | 4.363 | 3.761 | 13.098 | 17.110 | 9.766 | 9.248 |
| Net Profit/Loss - EUR | 7.059 | 4.379 | 3.689 | 2.410 | 4.137 | 3.596 | 12.849 | 16.498 | 9.543 | 8.623 |
| Employees | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Senzomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 549 | 453 | 356 | 262 | 166 | 82 | 12.316 | 11.889 | 9.883 | 7.990 |
| Current Assets | 12.725 | 4.756 | 5.819 | 8.150 | 12.091 | 17.534 | 11.938 | 15.746 | 13.207 | 9.902 |
| Inventories | 885 | 869 | 572 | 142 | 109 | 633 | 480 | 862 | 2.401 | 2.110 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 14.246 | 0 | 0 |
| Cash | 11.840 | 3.887 | 5.247 | 8.008 | 11.983 | 16.901 | 11.453 | 639 | 10.806 | 7.792 |
| Shareholders Funds | 13.037 | 4.432 | 3.741 | 6.082 | 10.112 | 13.516 | 23.826 | 20.975 | 16.285 | 13.854 |
| Social Capital | 45 | 45 | 44 | 43 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 237 | 776 | 2.434 | 2.330 | 2.146 | 2.132 | 429 | 5.141 | 5.562 | 4.038 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 2.001 | 0 | 1.533 | 1.338 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Senzomed S.r.l.